Lei Fan

机构：Union Hospital, Shanghai Medical College of Fudan University, Chinese Academy of Medical Sciences & Peking Union Medical College, Fudan University, Fudan University Shanghai Cancer Center, Shanghai Cancer Institute, Guang’anmen Hospital, Huazhong University of Science and Technology · ORCID：0000-0001-8914-7372

发表论文 103 篇 · 总被引 3516 次 · h-index 33

代表论文

• Alcohol consumption and risks of more than 200 diseases in Chinese men (2023 · Nature Medicine · 被引 188)
• Optimising first-line subtyping-based therapy in triple-negative breast cancer (FUTURE-SUPER): a multi-cohort, randomised, phase 2 trial (2024 · The Lancet Oncology · 被引 69)
• Camrelizumab vs Placebo in Combination With Chemotherapy as Neoadjuvant Treatment in Patients With Early or Locally Advanced Triple-Negative Breast Cancer (2024 · JAMA · 被引 47)
• Genetic interactions reveal distinct biological and therapeutic implications in breast cancer (2024 · Cancer Cell · 被引 41)
• Mobilizing antigen-presenting mast cells in anti-PD-1-refractory triple-negative breast cancer: a phase 2 trial (2025 · Nature Medicine · 被引 39)
• Comprehensive genomic profiling of breast cancers characterizes germline-somatic mutation interactions mediating therapeutic vulnerabilities (2023 · Cell Discovery · 被引 34)